@article{7ccd3c332c904b269e8893fd0a5deee9,
title = "Cefepime and all-cause mortality",
author = "Mical Paul and Dafna Yahav and Abigail Fraser and Leonard Leibovici",
note = "Funding Information: Potential conflicts of interest. P.G.P. has received research funding from Pfizer, Merck, Astellas, Basilea, and Schering-Plough and has been a consultant (ad hoc) for Merck, Basilea, and Optimer pharmaceuticals. C.A.K. has been on the speakers{\textquoteright} bureau for Pfizer and Astellas and has received research grants from Astellas and Merck. T.F.C. has been a consultant for Pfizer, Merck, and Novartis and has received honoraria from Pfizer, Merck, No-vartis, Schering-Plough, and Roche Diagnostics. B.-J.K. has been a consultant for Basilea, Novartis, Pfizer, and Schering-Plough and has been on the speakers{\textquoteright} bureau for MSD, Pfizer, and Schering-Plough. J.D.S. has received research funding from Merck and Pfizer, has served as a consultant for Merck and Pfizer, and has been on the speakers{\textquoteright} bureau for Pfizer, Merck, and Astellas.",
year = "2009",
month = aug,
day = "15",
doi = "10.1086/603587",
language = "אנגלית",
volume = "49",
pages = "640--641",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",
}